Julia Eduarda Schneider Gregório
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia Eduarda Schneider Gregório has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Guilherme Ferreira Caetano
University Center of Hermínio Ometto Foundation, FHO, Araras 13607-339, Brazil
2 shared publications - Milton Santamaria-Jr
Fundação Hermínio Ometto, Brazil
2 shared publications - Boyang Huang
Singapore Centre for 3D Printing School of Mechanical and Aerospace Engineering Nanyang Technological University Singapore 639798 Singapore
1 shared publication - Cian Vyas
Singapore Centre for 3D Printing School of Mechanical and Aerospace Engineering Nanyang Technological University Singapore 639798 Singapore
1 shared publication - Fernanda Carla Bombaldi de Souza
RCrio, Rua Cumarú, 204, Campinas 13098-324, Brazil
1 shared publication Gláucia Maria Tech dos Santos
University Center of Hermínio Ometto Foundation Araras SP Brazil
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (9) , e70152
Innovative In Vivo Approaches to Bone Regeneration: Combining Chitosan‐Xanthan Gum Membranes, Electrical Stimulation, and Laser Therapy
Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti‐inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm 2 ) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real‐time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced Runx‐2 and Osx expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated Il‐1β and pro‐inflammatory markers) alongside an anti‐inflammatory response. Conversely, compared with the CH/XG‐only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro‐inflammatory markers after 30 days, together with treatment‐ and time‐dependent changes in anti‐inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.
- 8 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (9) , e70152
Open AccessInnovative In Vivo Approaches to Bone Regeneration: Combining Chitosan‐Xanthan Gum Membranes, Electrical Stimulation, and Laser Therapy
Critical bone defects present significant clinical challenges due to their debilitating nature and associated costs. Tissue engineering offers a promising solution, employing biomaterials like porous chitosan (CH) and xanthan gum (XG) membranes as scaffolds for tissue regeneration. Electrical stimulation (ES) and laser (L) therapy, known for osteogenic and anti‐inflammatory effects, respectively, may synergistically enhance bone healing when combined with these membranes. This study evaluated CH/XG membranes and their association with ES and L for the treatment of critical bone defects (25 mm 2 ) created in 80 male Wistar rats. The animals were divided into four groups: untreated, CH/XG, CH/XG + ES, and CH/XG + L, assessed at days 30 and 90. Histomorphometric and real‐time PCR analyses revealed greater tissue and blood vessel formation in the CH/XG, CH/XG + ES, and CH/XG + L groups compared to the untreated group. At day 30, reduced Runx‐2 and Osx expression in the treated groups suggested an initial high inflammatory response. The CH/XG group showed pronounced inflammation (elevated Il‐1β and pro‐inflammatory markers) alongside an anti‐inflammatory response. Conversely, compared with the CH/XG‐only group, the CH/XG + ES and CH/XG + L groups generally showed lower expression of the evaluated pro‐inflammatory markers after 30 days, together with treatment‐ and time‐dependent changes in anti‐inflammatory markers. Although inflammation limited the initial effectiveness of CH/XG membranes, significant positive impacts were observed after 90 days. Combining membranes to cover bone defects and adjunctive therapies, as demonstrated in this study, emerges as a beneficial approach for enhancing bone repair outcomes. Adding osteoconductive or osteoinductive fillers may bring further healing improvements.
- Open Access
Early In Vivo Osteogenic and Inflammatory Response of 3D Printed Polycaprolactone/Carbon Nanotube/Hydroxyapatite/Tricalcium Phosphate Composite Scaffolds
The development of advanced biomaterials and manufacturing processes to fabricate biologically and mechanically appropriate scaffolds for bone tissue is a significant challenge. Polycaprolactone (PCL) is a biocompatible and degradable polymer used in bone tissue engineering, but it lacks biofunctionalization. Bioceramics, such as hydroxyapatite (HA) and β tricalcium phosphate (β-TCP), which are similar chemically to native bone, can facilitate both osteointegration and osteoinduction whilst improving the biomechanics of a scaffold. Carbon nanotubes (CNTs) display exceptional electrical conductivity and mechanical properties. A major limitation is the understanding of how PCL-based scaffolds containing HA, TCP, and CNTs behave in vivo in a bone regeneration model. The objective of this study was to evaluate the use of three-dimensional (3D) printed PCL-based composite scaffolds containing CNTs, HA, and β-TCP during the initial osteogenic and inflammatory response phase in a critical bone defect rat model. Gene expression related to early osteogenesis, the inflammatory phase, and tissue formation was evaluated using quantitative real-time PCR (RT-qPCR). Tissue formation and mineralization were assessed by histomorphometry. The CNT+HA/TCP group presented higher expression of osteogenic genes after seven days. The CNT+HA and CNT+TCP groups stimulated higher gene expression for tissue formation and mineralization, and pro- and anti-inflammatory genes after 14 and 30 days. Moreover, the CNT+TCP and CNT+HA/TCP groups showed higher gene expressions related to M1 macrophages. The association of CNTs with ceramics at 10wt% (CNT+HA/TCP) showed lower expressions of inflammatory genes and higher osteogenic, presenting a positive impact and balanced cell signaling for early bone formation. The association of CNTs with both ceramics promoted a minor inflammatory response and faster bone tissue formation.
Open AccessEarly In Vivo Osteogenic and Inflammatory Response of 3D Printed Polycaprolactone/Carbon Nanotube/Hydroxyapatite/Tricalcium Phosphate Composite Scaffolds
The development of advanced biomaterials and manufacturing processes to fabricate biologically and mechanically appropriate scaffolds for bone tissue is a significant challenge. Polycaprolactone (PCL) is a biocompatible and degradable polymer used in bone tissue engineering, but it lacks biofunctionalization. Bioceramics, such as hydroxyapatite (HA) and β tricalcium phosphate (β-TCP), which are similar chemically to native bone, can facilitate both osteointegration and osteoinduction whilst improving the biomechanics of a scaffold. Carbon nanotubes (CNTs) display exceptional electrical conductivity and mechanical properties. A major limitation is the understanding of how PCL-based scaffolds containing HA, TCP, and CNTs behave in vivo in a bone regeneration model. The objective of this study was to evaluate the use of three-dimensional (3D) printed PCL-based composite scaffolds containing CNTs, HA, and β-TCP during the initial osteogenic and inflammatory response phase in a critical bone defect rat model. Gene expression related to early osteogenesis, the inflammatory phase, and tissue formation was evaluated using quantitative real-time PCR (RT-qPCR). Tissue formation and mineralization were assessed by histomorphometry. The CNT+HA/TCP group presented higher expression of osteogenic genes after seven days. The CNT+HA and CNT+TCP groups stimulated higher gene expression for tissue formation and mineralization, and pro- and anti-inflammatory genes after 14 and 30 days. Moreover, the CNT+TCP and CNT+HA/TCP groups showed higher gene expressions related to M1 macrophages. The association of CNTs with ceramics at 10wt% (CNT+HA/TCP) showed lower expressions of inflammatory genes and higher osteogenic, presenting a positive impact and balanced cell signaling for early bone formation. The association of CNTs with both ceramics promoted a minor inflammatory response and faster bone tissue formation.